A first-in-human phase I dose escalation study of BET inhibitor GSK2820151 in patients with advanced or recurrent solid tumors cancers

被引：2

作者：

Gadgeel, Shirish

Keedy, Vicki

Taylor, Simon

Amin, Khalid

Homer, Thierry

Wu, Yuehui

Prinjha, Rab

Dhar, Arindam

Kremer, Brandon

机构：

来源：

CANCER RESEARCH | 2017年 / 77卷

关键词：

D O I：

10.1158/1538-7445.AM2017-CT104

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT104

引用

页数：2

共 50 条

[21] A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors [J].

Carducci, Michael A. ;

Wang, Ding ;

Habermehl, Christina ;

Bodding, Matthias ;

Rohdich, Felix ;

Lignet, Floriane ;

Duecker, Klaus ;

Karpenko, Oleksandr ;

Pudelko, Linda ;

Gimmi, Claude ;

LoRusso, Patricia .

CANCER RESEARCH COMMUNICATIONS, 2023, 3 (08) :1638-1647

[22] First-in-human phase I dose escalation study of the Bromodomain and Extra-Terminal motif (BET) inhibitor BAY 1238097 in subjects with advanced malignancies [J].

Postel-Vinay, S. ;

Herbschleb, K. ;

Massard, C. ;

Woodcock, V. ;

Ocker, M. ;

Wilkinson, G. ;

Walter, A. ;

Ewerton, F. ;

Poelman, M. ;

Middleton, M. ;

Soria, J. C. .

EUROPEAN JOURNAL OF CANCER, 2016, 69 :S7-S8

[23] A first-in-human phase I study of TAS-117, an allosteric AKT inhibitor, in patients with advanced solid tumors [J].

Doi, Toshihiko ;

Takahashi, Shunji ;

Aoki, Daisuke ;

Yonemori, Kan ;

Hara, Hiroki ;

Hasegawa, Kosei ;

Takehara, Kazuhiro ;

Harano, Kenichi ;

Yunokawa, Mayu ;

Nomura, Hiroyuki ;

Shimoi, Tatsunori ;

Horie, Koji ;

Ogasawara, Aiko ;

Okame, Shinichi .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (06) :605-616

[24] Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors [J].

Mathiot, Laurent ;

Combarel, David ;

Cagnat, Justin ;

Delahousse, Julia ;

Ouali, Kaissa ;

Marabelle, Aurelien ;

Loriot, Yohann ;

Ponce, Santiago ;

Champiat, Stephane ;

Broutin, Sophie ;

Danlos, Francois-Xavier .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (05)

[25] A first-in-human phase 1 dose escalation study of FF-10850 (liposomal topotecan) in patients with advanced solid tumors. [J].

Matulonis, Ursula A. ;

Janku, Filip ;

Moser, Justin C. ;

Fu, Siqing ;

Wages, David S. ;

Wheeler, Catherine A. ;

Mori, Mikinaga ;

Shimoyama, Susumu ;

Yamada, Naoki ;

Subach, Ruth Ann ;

Cheung, Kin ;

Madden, Timothy ;

Maier, Gary ;

Johansen, Mary ;

Falchook, Gerald Steven .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

[26] Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors [J].

Joerger, Markus ;

Calvo, Emiliano ;

Laubli, Heinz ;

Lopez, Juanita ;

Alonso, Guzman ;

de la Fuente, Elena Corral ;

Hess, Dagmar ;

Konig, David ;

Perez, Vicky Sanchez ;

Bucher, Christoph ;

Jethwa, Sangeeta ;

Garralda, Elena .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (11)

[27] A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors [J].

Rodon, Jordi ;

Tawbi, Hussein A. ;

Thomas, Anne L. ;

Stoller, Ronald G. ;

Turtschi, Christian P. ;

Baselga, Jose ;

Sarantopoulos, John ;

Mahalingam, Devalingam ;

Shou, Yaping ;

Moles, Melissa A. ;

Yang, Lin ;

Granvil, Camille ;

Hurh, Eunju ;

Rose, Kristine L. ;

Amakye, Dereck D. ;

Dummer, Reinhard ;

Mita, Alain C. .

CLINICAL CANCER RESEARCH, 2014, 20 (07) :1900-1909

[28] First-in-Human Phase I Dose Escalation Study of a Second-Generation Non-Ansamycin HSP90 Inhibitor, AT13387, in Patients with Advanced Solid Tumors [J].

Shapiro, Geoffrey I. ;

Kwak, Eunice ;

Dezube, Bruce J. ;

Yule, Murray ;

Ayrton, John ;

Lyons, John ;

Mahadevan, Daruka .

CLINICAL CANCER RESEARCH, 2015, 21 (01) :87-97

[29] Debio 1347, an oral FGFR inhibitor: Results from a first-in-human, phase I dose-escalation study in patients with FGFR genomically activated advanced solid tumors. [J].

Voss, Martin Henner ;

Hierro, Cinta ;

Heist, Rebecca Suk ;

Cleary, James M. ;

Meric-Bernstam, Funda ;

Gandhi, Leena ;

Ishii, Nobuya ;

Kirpicheva, Yulia ;

Nicolas-Metral, Valerie ;

Pokorska-Bocci, Anna ;

Purcea, Daniela ;

Vaslin, Anne ;

Moulon, Corinne ;

Zanna, Claudio ;

Flaherty, Keith ;

Tabernero, Josep ;

Baselga, Jose .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[30] A phase I first-in-human study of the polo-like kinase 1-selective inhibitor, GSK461364, in patients with advanced solid tumors [J].

Blagden, S. ;

Olmos, D. ;

Sharma, R. ;

Barriuso, J. ;

Medani, H. ;

Versola, M. ;

Murray, S. ;

Smith, D. A. ;

Dar, M. M. ;

deBono, J. S. .

EJC SUPPLEMENTS, 2008, 6 (12) :135-136

← 1 2 3 4 5 →